Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price

13.14 ▼ -0.37 (-2.74%)
Open: 13.35 Vol: 3.45K Day's range: 12.97 - 13.61 Apr 22, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TNXP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 13.11▲ 13.12▲ 13.13▲ 13.82▼ 13.28▼
MA10 13.09▲ 13.16▼ 13.35▼ 13.53▼ 13.61▼
MA20 13.10▲ 13.42▼ 13.75▼ 13.50▼ 15.24▼
MA50 13.17▼ 13.84▼ 13.83▼ 14.12▼ 24.21▼
MA100 13.42▼ 13.77▼ 13.55▼ 15.61▼ 35.48▼
MA200 13.78▼ 13.59▼ 13.94▼ 22.86▼ 4,281.49▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.011▲ -0.015▼ -0.093▼ 0.070▲ 0.564▲
RSI 52.052▲ 33.488▼ 33.204▼ 44.850▼ 39.559▼
STOCH 77.775     17.992▼ 9.155▼ 74.512     25.983    
WILL %R 0.000▲ -78.205▼ -87.072▼ -59.227     -81.584▼
CCI 68.382     -66.789     -89.637     -43.937     -62.732    
Latest Filters Detected On TNXP
RSI $TNXP RSI(14) Crossed Below 50 Set Alert
MA $TNXP Price Crossed Below MA(50) Set Alert
MA $TNXP Price Crossed Below MA(26) Set Alert
MA $TNXP Price Crossed Below MA(13) Set Alert
MA $TNXP Price Crossed Below MA(7) Set Alert
CDL $TNXP Marubozu Candlestick Pattern Detected Set Alert
Tonix Pharmaceuticals Holding Corp News
Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in ...
Wednesday, April 15, 2026 04:00 AM
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years TONMYA commercially ...
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World ...
Monday, March 30, 2026 10:59 PM
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Wednesday, March 18, 2026 09:58 AM
BERKELEY HEIGHTS, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, ...
TNXP historical stock data
date open high low close volume
22/04/26 13.35 13.61 12.97 13.14 379,880
21/04/26 14.32 14.35 13.48 13.51 293,673
20/04/26 13.83 14.44 13.70 14.34 308,382
17/04/26 14.35 14.39 13.86 13.98 370,873
16/04/26 14.52 14.52 13.46 14.13 483,788
15/04/26 13.35 14.40 13.35 14.34 654,329
14/04/26 13.10 13.89 12.93 13.35 789,146
13/04/26 12.40 13.335 12.19 12.98 376,352
10/04/26 13.07 13.2835 12.42 12.48 432,089
09/04/26 13.03 13.49 12.90 13.00 455,288
Quote Details
52wk Low:11.603
52wk High:69.97
Vol:3.45K
Avg Vol(3m):7.4M
1Y Chng:-31.35%
1M Chng:-6.01%
Add to Watch List
More Information
Index US Composite
Market Cap. 203.71M